Review: taking Gleevec and Vitamin b12 together


Summary

Drug interactions are reported only by a few people who take Gleevec and Vitamin b12 together. This review analyzes the effectiveness and drug interactions between Gleevec and Vitamin b12. It is created by eHealthMe based on reports of 1 person who the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Gleevec and Vitamin b12 >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Gleevec

Gleevec has active ingredients of imatinib mesylate. It is often used in chronic myeloid leukaemia. (latest outcomes from Gleevec 20,285 users)

Vitamin B12

Vitamin b12 has active ingredients of cyanocobalamin. It is often used in vitamin b12 deficiency. (latest outcomes from Vitamin b12 4,023 users)

On Jul, 25, 2016

1 person who takes Gleevec, Vitamin B12 are studied.


Number of reports submitted per year:

Gleevec and Vitamin b12 drug interactions.

Most common drug interactions over time *:

6 - 12 months:
  • acute myocardial infarction
  • asthenia
  • blood creatine phosphokinase increased
  • blood creatine phosphokinase mb
  • chest pain
  • dyspnoea
  • hypertension
  • red blood cell sedimentation rate increased
  • troponin t increased
not specified:
  • asthenia
  • blood creatine phosphokinase increased
  • blood creatine phosphokinase mb
  • chest pain
  • dyspnoea
  • hypertension
  • red blood cell sedimentation rate increased
  • troponin t increased
  • acute myocardial infarction

Most common drug interactions by gender *:

male:
  • acute myocardial infarction
  • asthenia
  • blood creatine phosphokinase increased
  • blood creatine phosphokinase mb
  • chest pain
  • dyspnoea
  • hypertension
  • red blood cell sedimentation rate increased
  • troponin t increased

Most common drug interactions by age *:

30-39:
  • acute myocardial infarction
  • asthenia
  • blood creatine phosphokinase increased
  • blood creatine phosphokinase mb
  • chest pain
  • dyspnoea
  • hypertension
  • red blood cell sedimentation rate increased
  • troponin t increased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Gleevec and Vitamin b12?

Can you answer these questions?

More questions for: Gleevec, Vitamin b12

You may be interested in these reviews

More reviews for: Gleevec, Vitamin b12

On eHealthMe, Gleevec (imatinib mesylate) is often used to treat chronic myeloid leukaemia. Vitamin b12 (cyanocobalamin) is often used to treat vitamin b12 deficiency. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.